Key Charpentier/Doudna CRISPR patent upheld by China National Intellectual Property Administration

RS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, today announced its patent CN201380038920.6 was upheld by the CNIPA in response to an invalidation challenge.

IN8bio’s Phase 1 AML data; Layoffs at Q32 Bio and Third Harmonic

Plus, news about Arvinas and Invizyne Technologies: IN8bio’s Phase 1 data in acute myeloid leukemia: In an investigator-sponsored study, all nine patients who received the

February 12, 2025

Peer-delivered psychotherapy effective for postpartum depression

An innovative model of care that offers new mothers psychotherapy delivered by other mothers who have also experienced post-partum depression (PPD) should be implemented in

August 31, 2023

Novel Drug-Device Shows Efficacy for High-Grade Cervical Lesions

SAN DIEGO — A novel, noninvasive, photodynamic drug-device combination was efficacious and safe for patients with cervical histologic high-grade squamous intraepithelial lesions (HSIL), a randomized

March 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.